1. Biomarkers of Diabetic Retinopathy
   Daniel Shu Wei Ting et al, 2016, Current Diabetes Reports CrossRef
2. Diabetic macular oedema: under‐represented in the genetic analysis of diabetic retinopathy
   Suzanne Broadgate et al, 2018, Acta Ophthalmologica CrossRef
3. Diyabetik Nefropatili Hastalarda Paraoksonaz 1 Gen Polimorfizmlerinin Araştırılması
   Feridun AKKAFA et al, 2022, Harran Üniversitesi Tıp Fakültesi Dergisi CrossRef
4. How HDL protects LDL against atherogenic modification
   Handrean Soran et al, 2015, Current Opinion in Lipidology CrossRef
5. The associations of PON1 and APOE polymorphisms with plasma lipid levels and the risk for late complications in type 2 diabetes patients
   Jasna Klen et al, 2023, Journal of Medical Biochemistry CrossRef
6. Developments in Ocular Genetics
   Inas F. Aboobakar et al, 2014, Asia-Pacific Journal of Ophthalmology CrossRef
7. The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis
   Chenfang Wu et al, 2018, Diabetes Therapy CrossRef
8. Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review
   Dominika Kunachowicz et al, 2023, International Journal of Environmental Research and Public Health CrossRef
9. Association of PON2 Gene Polymorphisms (Ser311Cys and Ala148Gly) With the Risk of Developing Type 2 Diabetes Mellitus in the Chinese Population
   Huan Ren et al, 2018, Frontiers in Endocrinology CrossRef
10. Insights into the role of paraoxonase 2 in human pathophysiology
    Fauzia Parween et al, 2022, Journal of Biosciences CrossRef
11. PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome
    Roshan Dadachanji et al, 2015, Fertility and Sterility CrossRef
12. Candidate gene studies of diabetic retinopathy in human
    Petra Priščáková et al, 2016, Molecular Biology Reports CrossRef
13. Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation
    Yasaman Shokri et al, 2020, Diabetes Research and Clinical Practice CrossRef
14. Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome
    Rok Herman et al, 2020, Metabolites CrossRef
15. Fucoidan protects ARPE-19 cells from oxidative stress via normalization of reactive oxygen species generation through the Ca2+-dependent ERK signaling pathway
    XIAOXIA LI et al, 2015, Molecular Medicine Reports CrossRef
16. Antioxidant properties of HDL
    Handrean Soran et al, 2015, Frontiers in Pharmacology CrossRef
17. Paraoxonase 1 (PON1)-L55M among common variants in the coding region of the paraoxonase gene family may contribute to the glycemic control in type 2 diabetes
    Abdolkarim Mahrooz et al, 2018, Clinica Chimica Acta CrossRef
18. Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1
    Yuhua Chen et al, 2019, Experimental Eye Research CrossRef